Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel B Longley

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
BMJ Oncology|January 31, 2025
Integrated multiplex analysis of cell death regulators in stage II colorectal cancer suggests patients with 'persister' cell profiles fail to benefit from adjuvant chemotherapySanghee Cho, Elizabeth McDonough, John Graf, et al.
British Journal of Cancer|September 11, 2020
Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancerMichelle K Greene, Ting Chen, Eifion Robinson, et al.
Molecular Cancer Therapeutics|August 14, 2021
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal CancerNyree Crawford, Katie J Stott, Tamas Sessler, et al.
Oncotarget|January 23, 2016
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapyChris W D Armstrong, Pamela J Maxwell, Chee Wee Ong, et al.
Journal of Cancer Policy|October 15, 2023
Health diplomacy in action: The cancer legacy of the Good Friday AgreementMark Lawler, Richard Sullivan, Ghassan K Abou-Alfa, et al.
Cell Death & Disease|October 30, 2020
RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancerHajrah Khawaja, Andrew Campbell, Jamie Z Roberts, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2020
DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo modelsMichael C Johnston, Julie A Nicoll, Kelly M Redmond, et al.
JCO Clinical Cancer Informatics|April 18, 2019
A Machine Learning Platform to Optimize the Translation of Personalized Network Models to the ClinicManuela Salvucci, Arman Rahman, Alexa J Resler, et al.
Cell Death & Disease|September 24, 2021
TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cellsJerzy A Woznicki, Nisha Saini, Peter Flood, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2021
Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populationsXanthi Stachtea, Maurice B Loughrey, Manuela Salvucci, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
BMJ Oncology|January 31, 2025
Integrated multiplex analysis of cell death regulators in stage II colorectal cancer suggests patients with 'persister' cell profiles fail to benefit from adjuvant chemotherapySanghee Cho, Elizabeth McDonough, John Graf, et al.
British Journal of Cancer|September 11, 2020
Controlled coupling of an ultrapotent auristatin warhead to cetuximab yields a next-generation antibody-drug conjugate for EGFR-targeted therapy of KRAS mutant pancreatic cancerMichelle K Greene, Ting Chen, Eifion Robinson, et al.
Molecular Cancer Therapeutics|August 14, 2021
Clinical Positioning of the IAP Antagonist Tolinapant (ASTX660) in Colorectal CancerNyree Crawford, Katie J Stott, Tamas Sessler, et al.
Oncotarget|January 23, 2016
PTEN deficiency promotes macrophage infiltration and hypersensitivity of prostate cancer to IAP antagonist/radiation combination therapyChris W D Armstrong, Pamela J Maxwell, Chee Wee Ong, et al.
Journal of Cancer Policy|October 15, 2023
Health diplomacy in action: The cancer legacy of the Good Friday AgreementMark Lawler, Richard Sullivan, Ghassan K Abou-Alfa, et al.
Cell Death & Disease|October 30, 2020
RALB GTPase: a critical regulator of DR5 expression and TRAIL sensitivity in KRAS mutant colorectal cancerHajrah Khawaja, Andrew Campbell, Jamie Z Roberts, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|June 7, 2020
DR5-targeted, chemotherapeutic drug-loaded nanoparticles induce apoptosis and tumor regression in pancreatic cancer in vivo modelsMichael C Johnston, Julie A Nicoll, Kelly M Redmond, et al.
JCO Clinical Cancer Informatics|April 18, 2019
A Machine Learning Platform to Optimize the Translation of Personalized Network Models to the ClinicManuela Salvucci, Arman Rahman, Alexa J Resler, et al.
Cell Death & Disease|September 24, 2021
TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cellsJerzy A Woznicki, Nisha Saini, Peter Flood, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 4, 2021
Stratification of chemotherapy-treated stage III colorectal cancer patients using multiplexed imaging and single-cell analysis of T-cell populationsXanthi Stachtea, Maurice B Loughrey, Manuela Salvucci, et al.
Pageof 12